Keith G. Heinzerling

2.8k total citations
55 papers, 1.7k citations indexed

About

Keith G. Heinzerling is a scholar working on Cellular and Molecular Neuroscience, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Keith G. Heinzerling has authored 55 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cellular and Molecular Neuroscience, 24 papers in Epidemiology and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Keith G. Heinzerling's work include Neurotransmitter Receptor Influence on Behavior (21 papers), Substance Abuse Treatment and Outcomes (18 papers) and Opioid Use Disorder Treatment (16 papers). Keith G. Heinzerling is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (21 papers), Substance Abuse Treatment and Outcomes (18 papers) and Opioid Use Disorder Treatment (16 papers). Keith G. Heinzerling collaborates with scholars based in United States, Australia and Bulgaria. Keith G. Heinzerling's co-authors include Steven Shoptaw, Walter Ling, Daniel Roche, Lara A. Ray, Matthew J. Worley, Aimee‐Noelle Swanson, Uyen Kao, Sean D. Young, Karen Miotto and Spencer Bujarski and has published in prestigious journals such as American Journal of Public Health, Cochrane Database of Systematic Reviews and Neuropsychopharmacology.

In The Last Decade

Keith G. Heinzerling

54 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith G. Heinzerling United States	25	710	544	352	347	253	55	1.7k
Martin H. Leamon United States	19	757 1.1×	265 0.5×	279 0.8×	185 0.5×	358 1.4×	38	1.7k
Marc Mooney United States	30	508 0.7×	234 0.4×	228 0.6×	220 0.6×	299 1.2×	50	1.8k
Leslie H. Lundahl United States	21	571 0.8×	415 0.8×	224 0.6×	315 0.9×	197 0.8×	70	1.5k
Ari D. Kalechstein United States	26	1.0k 1.4×	420 0.8×	93 0.3×	337 1.0×	529 2.1×	51	2.0k
Karen Drexler United States	22	587 0.8×	632 1.2×	696 2.0×	173 0.5×	132 0.5×	54	1.9k
G. William MacEwan Canada	22	513 0.7×	227 0.4×	129 0.4×	369 1.1×	1.4k 5.7×	82	2.7k
Emily B. Einstein United States	18	337 0.5×	566 1.0×	752 2.1×	276 0.8×	87 0.3×	32	1.8k
Marilyn Huckans United States	25	359 0.5×	486 0.9×	78 0.2×	114 0.3×	345 1.4×	48	1.9k
Ofra Sarid‐Segal United States	19	601 0.8×	306 0.6×	106 0.3×	217 0.6×	320 1.3×	27	1.3k
John J. Mariani United States	26	655 0.9×	647 1.2×	446 1.3×	825 2.4×	632 2.5×	67	2.1k

Countries citing papers authored by Keith G. Heinzerling

Since Specialization

Citations

This map shows the geographic impact of Keith G. Heinzerling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith G. Heinzerling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith G. Heinzerling more than expected).

Fields of papers citing papers by Keith G. Heinzerling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith G. Heinzerling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith G. Heinzerling. The network helps show where Keith G. Heinzerling may publish in the future.

Co-authorship network of co-authors of Keith G. Heinzerling

This figure shows the co-authorship network connecting the top 25 collaborators of Keith G. Heinzerling. A scholar is included among the top collaborators of Keith G. Heinzerling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith G. Heinzerling. Keith G. Heinzerling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heinzerling, Keith G., et al.. (2023). Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder. Frontiers in Psychiatry. 14. 1215972–1215972. 10 indexed citations

Kelly, Daniel F., et al.. (2022). Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology. Neurosurgery. 92(4). 680–694. 6 indexed citations

Young, Sean D., et al.. (2020). Social media as an emerging tool for reducing prescription opioid misuse risk factors. Heliyon. 6(3). e03471–e03471. 21 indexed citations

Heinzerling, Keith G., et al.. (2019). Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder. Journal of Neuroimmune Pharmacology. 15(2). 238–248. 22 indexed citations

Watkins, Katherine E., Allison J. Ober, Karen Lamp, et al.. (2017). Implementing the Chronic Care Model for Opioid and Alcohol Use Disorders in Primary Care. Progress in community health partnerships. 11(4). 397–407. 19 indexed citations

Shoptaw, Steven, Aimee‐Noelle Swanson, John Tsuang, et al.. (2017). Ibudilast may improve attention during early abstinence from methamphetamine. Drug and Alcohol Dependence. 178. 386–390. 17 indexed citations

Ray, Lara A., Spencer Bujarski, Steven Shoptaw, et al.. (2017). Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial. Neuropsychopharmacology. 42(9). 1776–1788. 97 indexed citations

Ober, Allison J., Katherine E. Watkins, Sarah B. Hunter, et al.. (2017). Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT study. BMC Family Practice. 18(1). 107–107. 26 indexed citations

Heinzerling, Keith G., Aimee‐Noelle Swanson, John Tsuang, et al.. (2016). Safety of Intravenous Methamphetamine Administration During Ibudilast Treatment. Journal of Clinical Psychopharmacology. 36(4). 347–354. 18 indexed citations

10.

Heinzerling, Keith G., et al.. (2016). SUMMIT: Procedures for Medication-Assisted Treatment of Alcohol or Opioid Dependence in Primary Care. RAND Corporation eBooks. 4 indexed citations

11.

Heinzerling, Keith G., et al.. (2015). Association of gender and genetic ancestry with frequency of methamphetamine use among methamphetamine-dependent Hispanic and non-Hispanic Whites. Drug and Alcohol Dependence. 156. e94–e94. 1 indexed citations

12.

Swanson, Aimee‐Noelle, Matthew Wright, John Tsuang, et al.. (2014). Ibudilast may reduce inattention associated with methamphetamine use. Drug and Alcohol Dependence. 140. e220–e221. 1 indexed citations

13.

Heinzerling, Keith G., et al.. (2013). Pilot Randomized Trial of Bupropion for Adolescent Methamphetamine Abuse/Dependence. Journal of Adolescent Health. 52(4). 502–505. 21 indexed citations

14.

Heinzerling, Keith G., et al.. (2012). Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment. Drug and Alcohol Review. 32(1). 96–99. 33 indexed citations

15.

Ling, Walter, Steven Shoptaw, Maureen Hillhouse, et al.. (2011). Double‐blind placebo‐controlled evaluation of the PROMETA™ protocol for methamphetamine dependence. Addiction. 107(2). 361–369. 24 indexed citations

16.

Garza, Richard De La, Todd Zorick, Keith G. Heinzerling, et al.. (2009). The cardiovascular and subjective effects of methamphetamine combined with γ-vinyl-γ-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers. Pharmacology Biochemistry and Behavior. 94(1). 186–193. 14 indexed citations

17.

Shoptaw, Steven, Uyen Kao, Keith G. Heinzerling, & Walter Ling. (2009). Treatment for amphetamine withdrawal. Cochrane Database of Systematic Reviews. CD003021–CD003021. 74 indexed citations

18.

Shoptaw, Steven, Keith G. Heinzerling, Erin Rotheram‐Fuller, et al.. (2008). Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence. Drug and Alcohol Dependence. 96(3). 222–232. 110 indexed citations

19.

Heinzerling, Keith G., Alex H. Kral, Neil M. Flynn, et al.. (2007). Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: Availability and outcomes. Journal of Substance Abuse Treatment. 32(4). 423–429. 9 indexed citations

20.

Heinzerling, Keith G., et al.. (2006). Hospital Utilization for Injection Drug Use-Related Soft Tissue Infections in Urban versus Rural Counties in California. Journal of Urban Health. 83(2). 176–181. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact